Cancer survivor, Samantha Currie
Anything that speeds up diagnosis and access to treatment is welcome as getting treatment quickly improves your chances of beating the disease.
Cancer survivor Samantha Currie, 42, from Menstrie in Stirlingshire, welcomed the new initiative.
The primary teacher visited her GP after finding a lump in her right breast in October 2021. She was referred to Forth Valley Royal Hospital for a mammogram, ultrasound and biopsy.
Within two weeks she was told she had triple negative breast cancer that has spread to her lymph nodes and underwent months of treatment including chemotherapy every three weeks, surgery and radiotherapy.
She said: “My cancer was diagnosed quickly after visiting my GP but anything that speeds up diagnosis and access to treatment is welcome as getting treatment quickly improves your chances of beating the disease.”
Samantha’s cancer is now in remission, back at work and enjoying life with husband John and children Emma, 14, and Tom, four.
Naser Turabi, Director of Evidence and Implementation at Cancer Research UK, said: “We are delighted to support these new projects and hope taking a patient-focused approach will reap enormous benefits to the patients experiencing these new pathways in Scotland.
“If patients in these schemes are diagnosed faster and are able to access treatment more quickly improving their outcomes, then we hope this pathway could be available permanently to patients in the pilot areas - and adopted elsewhere in Scotland and across the UK.”
TET has received Cancer Research UK funding of £900,000 for pilots in the first year, including these two in Scotland, with each project working in conjunction with local NHS teams to find new ways to improve both patient experience and cancer outcomes.
Brian Knowles, Test Evidence Transition Programme Lead at Cancer Research UK, said: "Test Evidence Transition is an exciting new approach which we hope will significantly improve the way people experience their cancer diagnosis.
“These services are among the first of many, which could establish new ways of working to improve cancer outcomes for everyone.”